Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions

Published:2014-09-26 Issue:5 Volume:60 Page:1776-1782
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hato Tai¹,Goyal Lipika²,Greten Tim F.³,Duda Dan G.¹,Zhu Andrew X.²

Affiliation:

1. Edwin L. Steele Laboratory, Department of Radiation Oncology; Massachusetts General Hospital; Boston MA

2. Hematology/Oncology, Department of Medicine; Massachusetts General Hospital Cancer Center; Boston MA

3. Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Oncology Branch; National Cancer Institute; Bethesda MD

Funder

National Cancer Institute

American Cancer Society

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27246/fullpdf

Reference62 articles.

1. Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response;Huz;HPB,2012

2. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C;Sangro;J Hepatol,2013

3. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma;Ohnishi;Hepatology,1998

4. Percutaneous ethanol injection therapy for hepatocellular carcinoma;Shiina;A histopathologic study. Cancer,1991

5. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma;Korangy;Clin Cancer Res,2004

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and clinical significance of NLRC5 in hepatocellular carcinoma;Cancer Biology & Therapy;2024-08-12

2. Nivolumab as Second-Line Therapy Improves Survival in Patients with Unresectable Hepatocellular Carcinoma;Cancers;2024-06-11

3. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant;Journal of Gastrointestinal Cancer;2024-03-14

4. Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma;BMC Cancer;2024-03-04

5. Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma;Functional & Integrative Genomics;2024-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3